facebook-page-view
Advertisement

InvaGen Pharmaceuticals Inc

Cipla subsidiary gets termination notice on $215 million deal with US firm Avenue Therapeutics

Healthcare

03 November, 2021

Cipla subsidiary gets termination notice on $215 million deal with US firm Avenue Therapeutics

Indian drugmaker Cipla Ltd said its subsidiary InvaGen Pharmaceuticals has received a notice of termination on a three year old ......

Cipla to acquire US-based speciality drugmaker Avenue Therapeutics

Healthcare

13 November, 2018

Cipla to acquire US-based speciality drugmaker Avenue Therapeutics

Indian drugmaker Cipla Ltd said Tuesday it has signed pacts to acquire Nasdaq-listed speciality pharmaceutical company Avenue Therapeutics Inc. for ......